FMP
Apr 02, 2022(Last modified: Dec 19, 2023)
Walgreens Boots (NASDAQ:WBA) shares lost around 7% since the company’s reported Q2 results two days ago. While the company beat the Street expectations, the guidance of low-single-digit EPS growth was reiterated, implying a significant deceleration in H2/22 due to labor and Walgreens Health investments.
Q2 adjusted EPS came in at $1.59, compared to the estimates of $1.37, and revenue at $33.76 billion, compared to the consensus of $33.32 billion. The company benefited from strong vaccination and testing demand, solid US retail demand, and continued improvement in international markets.
Analysts at RBC Capital reiterated their Sector Perform rating but lowered their price target to $46 from $52 as they roll their valuation forward to 2023 to reflect a more normalized post-pandemic operating backdrop.

In times of rising geopolitical tension or outright conflict, defense stocks often outperform the broader market as gove...

As Circle Internet (NYSE:CRCL) gains attention following its recent public listing, investors are increasingly scrutiniz...

LVMH Moët Hennessy Louis Vuitton (OTC:LVMUY) is a global leader in luxury goods, offering high-quality products across f...